(Q37865169)

24 August 2017

1 reference

title

Fanconi anaemia: from a monogenic disease to sporadic cancer (English)

1 reference

24 August 2017

1 reference

Antonio Valeri

1

1 reference

24 August 2017

Sandra Martínez

series ordinal

2

1 reference

24 August 2017

José A Casado

series ordinal

3

1 reference

24 August 2017

Juan A Bueren

series ordinal

4

1 reference

24 August 2017

language of work or name

1 reference

1 April 2011

1 reference

Clinical and Translational Oncology

24 August 2017

published in

1 reference

24 August 2017

volume

13

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

215-221

1 reference

A 20-year perspective on the International Fanconi Anemia Registry (IFAR).

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Oxidative stress in Fanconi anemia hematopoiesis and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Mutation of the RAD51C gene in a Fanconi anemia-like disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Expanded roles of the Fanconi anemia pathway in preserving genomic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

A novel ubiquitin ligase is deficient in Fanconi anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

FANCM-FAAP24 and FANCJ: FA proteins that metabolize DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

FAN1 Acts with FANCI-FANCD2 to Promote DNA Interstrand Cross-Link Repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

The Fanconi anemia protein interaction network: casting a wide net.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

ATR couples FANCD2 monoubiquitination to the DNA-damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Nijmegen breakage syndrome diagnosed as Fanconi anaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Disruption of the FA/BRCA pathway in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Expression of oncogenic kinase Bcr-Abl impairs mitotic checkpoint and promotes aberrant divisions and resistance to microtubule-targeting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Fanconi anemia (cross)linked to DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

How the fanconi anemia pathway guards the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

DNA repair pathways as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

A 3.(ET743)-DNA complex that both resembles an RNA-DNA hybrid and mimicks zinc finger-induced DNA structural distortions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

BRCA-FA pathway as a target for anti-tumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

The concept of synthetic lethality in the context of anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

CHK1 inhibition as a strategy for targeting Fanconi Anemia (FA) DNA repair pathway deficient tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Methylation status of CpG islands at sites -59 to +96 in exon 1 of the BRCA2 gene varies in mammary tissue among women with sporadic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

FANCF methylation contributes to chemoselectivity in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

Molecular pathogenesis of Fanconi anemia: recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0645-6

A somatic truncating mutation in BRCA2 in a sporadic breast tumor.

21 January 2018

1 reference

12 December 2020

Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma

1 reference

12 December 2020

Inactivation of BRCA1 and BRCA2 in ovarian cancer

1 reference

12 December 2020

Fanconi anemia gene mutations in young-onset pancreatic cancer

1 reference

12 December 2020

Novel somatic mutations in the BRCA1 gene in sporadic breast tumors

1 reference

12 December 2020

Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer

1 reference

12 December 2020

Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition

1 reference

12 December 2020

No evidence for FANCF gene silencing in head-and-neck squamous cell carcinomas.

1 reference

12 December 2020

High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cells

1 reference

12 December 2020

Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.

1 reference

12 December 2020

CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer

1 reference

12 December 2020

High frequency of BRCA1/2 and p53 somatic inactivation in sporadic ovarian cancer

1 reference

12 December 2020

Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma

1 reference

12 December 2020

No evidence of significant silencing of Fanconi genes FANCF and FANCB or Nijmegen breakage syndrome gene NBS1 by DNA hyper-methylation in sporadic childhood leukaemia

1 reference

12 December 2020

Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization

1 reference

12 December 2020

10.1007/S12094-011-0645-6

Identifiers

DOI

1 reference

24 August 2017

1 reference